152 related articles for article (PubMed ID: 20574759)
1. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
[TBL] [Abstract][Full Text] [Related]
2. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.
Hancer VS; Diz-Kucukkaya R; Aktan M
Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
[TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
7. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
[TBL] [Abstract][Full Text] [Related]
8. [Expression and Clinical Significance of Helper T Cells 9 and Its Sytokines Interleukin 9 in Chronic Lymphocytic Leukemia].
Shabaaiti T; Pang NN; Xierenguli A; Nazhakaiti Y; Guo S; Zhang RR; Gong S; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1663-1669. PubMed ID: 38071043
[TBL] [Abstract][Full Text] [Related]
9. [Detection of puma mRNA levels by real-time quantitative RT-PCR in chronic lymphocytic leukemia and its clinical significance].
Zhu HJ; Xu W; Cao X; Fang C; Zhu DX; Dong HJ; Wang DM; Qiao C; Miao KR; Liu P; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):843-8. PubMed ID: 20723285
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM
Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009
[TBL] [Abstract][Full Text] [Related]
11. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
[TBL] [Abstract][Full Text] [Related]
14. [mRNA Expressions of T-bet, GATA-3, ROR γt and Foxp3 in peripheral blood of patients with chronic lymphocytic leukemia in different stages].
Yu JJ; Chen G; Pang NN; Guo XH; Wang L; Zhao F; Tan MF; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):45-9. PubMed ID: 25687044
[TBL] [Abstract][Full Text] [Related]
15. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
16. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
[TBL] [Abstract][Full Text] [Related]
17. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.
Aalto Y; El-Rifa W; Vilpo L; Ollila J; Nagy B; Vihinen M; Vilpo J; Knuutila S
Leukemia; 2001 Nov; 15(11):1721-8. PubMed ID: 11681413
[TBL] [Abstract][Full Text] [Related]
18. Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.
Wang Y; Ma L; Wang C; Sheng G; Feng L; Yin C
Int J Mol Med; 2015 Sep; 36(3):627-32. PubMed ID: 26136223
[TBL] [Abstract][Full Text] [Related]
19. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
[TBL] [Abstract][Full Text] [Related]
20. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
